Skip to content
ChickenStockChickenStock
Research005250
GC logo

GC (005250) stock

KOSPI · Pharmaceuticals

KRW 9,630+2.34%(+220)

As of Nov 10, 9:02 AM KST

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 10, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-3.71x

Net loss — not comparable

P/B

0.52x

P/S

0.18x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Consolidated · Filed Aug 14, 2026KRW 596.3 billionKRW 6.6 billionKRW 1.3 billion-0.7%
Q1 2026Consolidated · Filed May 15, 2026KRW 534.8 billionKRW 3.1 billion-KRW 29.6 billion+8.1%
Q4 2025Consolidated · Filed Mar 18, 2026KRW 619.5 billion-KRW 6.7 billion-KRW 141.9 billion—
Q3 2025Consolidated · Filed Nov 14, 2025KRW 736.9 billionKRW 26 billionKRW 19 billion+20.8%
Q2 2025Consolidated · Filed Aug 14, 2025KRW 600.6 billionKRW 21.7 billionKRW 62.9 billion+7.3%
Q1 2025Consolidated · Filed May 15, 2025KRW 494.6 billion-KRW 4.8 billionKRW 18.2 billion+5.2%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 18, 2026KRW 2.5 trillionKRW 36.2 billion-KRW 41.8 billion—
FY2024Consolidated · Filed Mar 18, 2025KRW 2.2 trillion-KRW 10.7 billion-KRW 11.1 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
14.40%
Of trading value on Nov 9, 2026
Short-sale value
KRW 120 million
Previous 20-day average 9.79%
Net short position
94,708 shares
As of Nov 5, 2026 · reported with a two-trading-day lag
Lending balance
1,203,710 shares
As of Nov 9, 2026 · 2.56% of listed shares
Recent short-sale days
DateShareValue
Nov 9, 202614.40%KRW 120 million
Nov 6, 202610.57%KRW 110 million
Nov 5, 202618.81%KRW 200 million
Nov 4, 20267.68%KRW 50 million
Nov 3, 202614.76%KRW 90 million
Nov 2, 202613.49%KRW 80 million
Oct 30, 202612.19%KRW 100 million
Oct 29, 202626.85%KRW 160 million
Oct 28, 202611.44%KRW 50 million
Oct 27, 202610.29%KRW 90 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

GC (005250) stock information

KOSPI

GC (005250) is listed on KOSPI. Its market capitalization is about KRW 452.9 billion. On trailing-twelve-month earnings the P/E ratio is -3.71, and the P/B ratio is 0.52. Return on equity is -14.1%. These figures are computed in-house from official filings and are reference information only.

GC — frequently asked questions

What is the P/E ratio of GC (005250)?
On a trailing-twelve-month basis, 005250 trades at a P/E ratio of -3.71. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of GC?
005250 has a market capitalization of about KRW 452.9 billion. The figure moves with the share price and is refreshed each trading day.
Does GC pay a dividend?
005250 has a dividend yield of about 3.12%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.